Two Chinese Biotechs Raise $104m To Challenge GSK’s Shingrix

 
• By Dexter Jie Yan
  
fund raising
MAXVAX and Luzhu expected to roll out vaccines to challenge GSK's Shingrix inside and outside China • Source: Alamy
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia